封面
市场调查报告书
商品编码
1621857

葡萄醣醛酸内酯市场机会、成长动力、产业趋势分析与预测 2024 - 2032

Glucuronolactone Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 235 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年,全球葡萄醣醛酸内酯市场估值达到4.343亿美元,预计2024年至2032年复合年增长率将超过5.7%。功能性饮料中得到了广泛应用,其中因其增强能量、增强认知能力和支持排毒的能力而受到重视。消费者偏好转向天然和清洁标籤产品,进一步推动了市场成长,促使製造商将葡萄醣醛酸内酯融入新配方中。健身和健康趋势的日益流行,加上人们对功能性成分的认识不断提高,极大地促进了其在运动营养市场的成长。人们对健康产品的兴趣日益浓厚,预计将在未来几年扩大葡萄醣醛酸内酯的应用范围,为各个健康领域的更多创新产品开发铺平道路。

2023 年,粉末形式的葡萄醣醛酸内酯占据主导地位,市场份额为2.838 亿美元,预计2024 年至2032 年复合年增长率为5.8%。可以轻鬆融入膳食补充品和其他产品。此外,粉状葡萄醣醛酸内酯具有更好的货架稳定性和寿命,为製造商提供了适合各种应用的经济高效的成分。这种形式的流行是由于人们越来越认识到葡萄醣醛酸内酯在能量代谢和解毒中的作用,这引起了注重健康的消费者的强烈共鸣。与功能性饮料相关的细分市场也表现强劲,2023 年价值超过1.657 亿美元,预计到2032 年复合年增长率为5.8%。葡萄醣醛酸内酯是因其增强耐力和对抗疲劳的能力而被纳入其中。

随着新饮料品牌的出现,对葡萄醣醛酸内酯等功能性成分的需求将会成长,特别是随着年轻一代寻求支持身心表现的产品。在分销方面,线上零售在2023 年占据了1.532 亿美元的领先份额,预计到2032 年将以5.9% 的复合年增长率增长。轻鬆取得各种商品。美国市场也表现强劲,2023 年估值为8,570 万美元,预计到2032 年复合年增长率为5.7%。 这种增长是由消费者对健康和健身产品的高度兴趣、强大的分销网络和针对美国量身订製的创新所推动的。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 4.343 亿美元
预测值 7.119 亿美元
复合年增长率 5.7%

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
    • 影响价值链的因素
    • 利润率分析
    • 干扰
    • 未来展望
    • 製造商
    • 经销商
  • 供应商格局
  • 利润率分析
  • 重要新闻和倡议
  • 监管环境
  • 衝击力
    • 成长动力
      • 对能量饮料和功能性食品的需求不断增加
      • 消费者对膳食补充剂的健康意识不断增强
      • 运动营养和性能增强产品越来越受欢迎
      • 产品配方和输送系统的创新
    • 产业陷阱与挑战
      • 来自替代能源增强成分的竞争日益激烈
      • 与葡萄醣醛酸内酯相关的潜在健康问题和副作用
  • 成长潜力分析
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略展望矩阵

第 5 章:市场估计与预测:依表格,2021-2032

  • 主要趋势
  • 粉末
  • 胶囊/片剂

第 6 章:市场估计与预测:按应用划分,2021-2032 年

  • 主要趋势
  • 能量饮料
  • 补充品和营养保健品
  • 药品
  • 化妆品和个人护理
  • 食品饮料添加剂
  • 其他的

第 7 章:市场估计与预测:按配销通路,2021-2032 年

  • 主要趋势
  • 网路零售
  • 药局/药局
  • 超市/大卖场
  • 专业健康商店
  • 其他的

第 8 章:市场估计与预测:按地区,2021-2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 俄罗斯
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 墨西哥
  • MEA
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 9 章:公司简介

  • Aadhunik Industries
  • Anhui Fubore Pharmaceutical & Chemical
  • Anmol Chemicals
  • Foodchem International
  • FUJIFILM Wako Pure Chemical Corporation
  • Hubei Yitai Pharmaceutical
  • Jungbunzlauer
  • Merck
  • Muby Chemicals
  • Shandong Fuyuan Bio-Tech
简介目录
Product Code: 12076

The Global Glucuronolactone Market reached a valuation of USD 434.3 million in 2023 and is projected to grow at a CAGR exceeding 5.7% from 2024 to 2032. As demand rises across various industries, glucuronolactone has found broad application in dietary supplements and functional beverages, where it is valued for its ability to boost energy, enhance cognitive performance, and support detoxification. Market growth is further fueled by shifting consumer preferences towards natural and clean-label products, motivating manufacturers to integrate glucuronolactone into new formulations. The increasing popularity of fitness and wellness trends, combined with a greater awareness of functional ingredients, has contributed significantly to its growth in the sports nutrition market. This heightened interest in health-oriented products is expected to expand the scope of glucuronolactone applications over the coming years, paving the way for more innovative product development in various health-focused sectors.

In 2023, the powder form of glucuronolactone dominated with a market share of USD 283.8 million, anticipated to grow at a 5.8% CAGR from 2024 to 2032. The powder segment is particularly favored for its versatility, which allows easy integration into dietary supplements and other health products. In addition, powdered glucuronolactone offers better shelf stability and longevity, providing manufacturers with a cost-effective ingredient for a range of applications. The popularity of this form is driven by increasing awareness of glucuronolactone's role in energy metabolism and detoxification, which resonates strongly with health-conscious consumers. The market segment linked to functional beverages also performed robustly, holding a value of over USD 165.7 million in 2023, with an expected CAGR of 5.8% through 2032. The demand for energy-boosting products aligns with consumer trends toward active lifestyles, where glucuronolactone is incorporated for its capacity to enhance endurance and combat fatigue.

As new beverage brands emerge, the demand for functional ingredients like glucuronolactone is set to grow, particularly as younger demographics seek out products that support physical and mental performance. In terms of distribution, online retail captured a leading share of USD 153.2 million in 2023 and is forecasted to grow at 5.9% CAGR until 2032. The convenience of e-commerce has made it a preferred purchasing method, allowing consumers easy access to a variety of glucuronolactone products, along with price comparisons and customer reviews. The U.S. market also demonstrated strong performance, with a valuation of USD 85.7 million in 2023 and an anticipated 5.7% CAGR through 2032. This growth is driven by high consumer interest in wellness and fitness products, alongside a robust distribution network and innovations tailored to U.S. consumer preferences.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$434.3 Million
Forecast Value$711.9 Million
CAGR5.7%

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Forecast calculations
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry synopsis, 2021-2032

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Factor affecting the value chain
    • 3.1.2 Profit margin analysis
    • 3.1.3 Disruptions
    • 3.1.4 Future outlook
    • 3.1.5 Manufacturers
    • 3.1.6 Distributors
  • 3.2 Supplier landscape
  • 3.3 Profit margin analysis
  • 3.4 Key news & initiatives
  • 3.5 Regulatory landscape
  • 3.6 Impact forces
    • 3.6.1 Growth drivers
      • 3.6.1.1 Increasing demand for energy drinks and functional foods
      • 3.6.1.2 Growing health awareness among consumers regarding dietary supplements
      • 3.6.1.3 Rising popularity of sports nutrition and performance-enhancing products
      • 3.6.1.4 Innovation in product formulations and delivery systems
    • 3.6.2 Industry pitfalls & challenges
      • 3.6.2.1 Increasing competition from alternative energy-boosting ingredients
      • 3.6.2.2 Potential health concerns and side effects associated with glucuronolactone
  • 3.7 Growth potential analysis
  • 3.8 Porter's analysis
  • 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Competitive positioning matrix
  • 4.4 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Form, 2021-2032 (USD Million) (Units)

  • 5.1 Key trends
  • 5.2 Powder
  • 5.3 Capsule/tablets

Chapter 6 Market Estimates & Forecast, By Application, 2021-2032 (USD Million) (Units)

  • 6.1 Key trends
  • 6.2 Energy drinks
  • 6.3 Supplements & nutraceuticals
  • 6.4 Pharmaceuticals
  • 6.5 Cosmetics & personal care
  • 6.6 Food & beverage additives
  • 6.7 Others

Chapter 7 Market Estimates & Forecast, By Distribution Channel, 2021-2032 (USD Million) (Units)

  • 7.1 Key trends
  • 7.2 Online retail
  • 7.3 Pharmacies/drugstores
  • 7.4 Supermarkets/hypermarkets
  • 7.5 Specialty health stores
  • 7.6 Others

Chapter 8 Market Estimates & Forecast, By Region, 2021-2032 (USD Million) (Units)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 UK
    • 8.3.2 Germany
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Russia
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 India
    • 8.4.3 Japan
    • 8.4.4 South Korea
    • 8.4.5 Australia
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
  • 8.6 MEA
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Aadhunik Industries
  • 9.2 Anhui Fubore Pharmaceutical & Chemical
  • 9.3 Anmol Chemicals
  • 9.4 Foodchem International
  • 9.5 FUJIFILM Wako Pure Chemical Corporation
  • 9.6 Hubei Yitai Pharmaceutical
  • 9.7 Jungbunzlauer
  • 9.8 Merck
  • 9.9 Muby Chemicals
  • 9.10 Shandong Fuyuan Bio-Tech